Eosinophil Peroxidase: Clinical Trials

6 trials of Eosinophil Peroxidase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 unknown. 3 Phase 2, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Unknown 1
Phase 32Completed 1, Terminated 1
Phase 41Completed 1

Follow Eosinophil Peroxidase: new trials by email Literature Review of Eosinophil Peroxidase trials Research Report on Eosinophil Peroxidase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Erythropoietin in Premature Infants to Prevent Encephalopathy
Epo, Normal saline - Premature Infant
Phase 2TerminatedChildren's Hospital of Fudan University582015-09-082023-12-29
Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)
Epo, Control - Extreme Prematurity
Phase 3CompletedUniversity of Washington9412013-12-012026-05-19
The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis
Erythropoietin - Multiple Sclerosis (Primary or Secondary Progressive Phase).
Phase 2UnknownCopenhagen University Hospital, Rigshospitalet562009-11-012011-08-08
Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder
Erythropoietin - Mood Disorders
Phase 2CompletedLars Vedel Kessing, professor, MD, DMSc.832009-09-012012-11-09
Erythropoietin and Platelet Activation Markers
erythropoietin - Thrombosis, Hypertension
Phase 4CompletedMedical University of Vienna122006-11-012011-07-14
REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
erythropoietin - Kidney Failure, Chronic, Drug Resistance
Phase 3TerminatedQueen's University62006-10-012009-02-12

Conditions studied

Premature Birth (2)  ·  Bipolar Disorder (1)  ·  Coitus (1)  ·  Depression (1)  ·  Hypertension (1)  ·  Kidney Failure, Chronic (1)  ·  Mood Disorders (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Chronic Progressive (1)  ·  Thrombosis (1)

Sponsors

Children's Hospital of Fudan University (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Lars Vedel Kessing, professor, MD, DMSc. (1)  ·  Medical University of Vienna (1)  ·  Queen's University (1)  ·  University of Washington (1)

Countries

Denmark (2)  ·  Austria (1)  ·  Canada (1)  ·  China (1)  ·  United States (1)

Top investigators

Karen E Yeates, MD, FRCP(C), MPH (1)  ·  Karen Schreiber, MD., Ph.d. (1)  ·  Lars V Kessing, Professor (1)  ·  Michael Wolzt, Prof. (1)  ·  Per S Soerensen, MD., Prof (1)  ·  Sandra E Juul, MD, PhD (1)  ·  Wenhao Zhou, Doctor (1)

Results publications

PMID 20942940, PMID 22098110, PMID 25099079, PMID 25641635, PMID 26011424, PMID 26996196, PMID 27057344, PMID 27259062, PMID 27835716, PMID 28821985, PMID 31804779, PMID 31940698, PMID 32488672, PMID 32804205, PMID 33113526, PMID 34117080, PMID 34324880, PMID 34845352, PMID 35338252, PMID 35725917, PMID 35853728, PMID 36580332, PMID 37561461, PMID 37790304, PMID 37926336, PMID 38195921, PMID 38195922, PMID 39390245, PMID 41214292, PMID 41222934, PMID 42012687

NIH funding

U01NS077953 (1)